Clinical Study
Pain Control after Total Knee Arthroplasty: Comparing Intra-Articular Local Anesthetic Injection with Femoral Nerve Block
Table 2
Comparison of use of NSAIDs between IALA and FNB group.
| | IALA group () | FNB group () | value |
| Ketorolac 30 mg (i.v.) in PACU | 9 | 15 | 0.81 | Acetaminophen 500 mg QID in the ward | 39 | 55 | 1.000 | NSAIDs in the ward | 18 | 54 | <0.0001 | Aceclofenac 100 mg BID | 1 | 2 | | Acemetacin 90 mg QD | 0 | 1 | | Acemetacin 90 mg BID | 0 | 6 | | Celecoxib 200 mg QD | 0 | 29 | | Celecoxib 200 mg BID | 0 | 5 | | Diclofenac 25 mg TID | 0 | 1 | | Diclofenac 25 mg QID | 0 | 1 | | Etodolac 400 mg QD | 0 | 2 | | Etoricoxib 120 mg QD | 12 | 0 | | Mefenamic acid 250 mg QID | 0 | 4 | | Naproxen 250 mg BID | 0 | 1 | | Parecoxib 40 mg Q12 H | 5 | 2 | |
|
|
BID: twice daily; TID: thrice daily; QID: 4 times a day; Q12 H: every 12 hours.
|